GRANULICATELLA BACTERAEMIA

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting GRANULICATELLA BACTERAEMIA:

# Drug Count
0 TACROLIMUS 8
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 8
2 TACROLIMUS OINTMENT 0.1% 8
3 METHYLPREDNISOLONE 7
4 MYCOPHENOLATE MOFETIL 6
5 BORTEZOMIB 4
6 PREDNISONE 4
7 CYTARABINE 3
8 RITUXIMAB 3
9 SIROLIMUS 3
See all common drugs associated with GRANULICATELLA BACTERAEMIA

GRANULICATELLA BACTERAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRINCIDOFOVIR 1 0.0072
1 ARGATROBAN 1 0.0007
2 IMIPENEM AND CILASTATIN SODIUM 1 0.0005
3 RASBURICASE 1 0.0004
4 MICAFUNGIN SODIUM 2 0.0003
5 SIROLIMUS 3 0.0002
6 PYRAZINAMIDE 2 0.0002
7 OFLOXACIN OTIC SOLUTION 1 0.0001
8 OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% 1 0.0001
9 OFLOXACIN OTIC 1 0.0001
See all drugs enriched for association with GRANULICATELLA BACTERAEMIA

GRANULICATELLA BACTERAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anti-coagulant [EPC] 1 0.0003
1 Echinocandin Antifungal [EPC] 2 0.0002
2 Lipopeptide Antibacterial [EPC] 1 0.0001
3 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
4 Antifibrinolytic Agent [EPC] 1 0.0001
5 Quinolone Antimicrobial [EPC] 1 0.0001
6 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
7 Antimalarial [EPC] 1 0.0001
8 Antiprotozoal [EPC] 1 0.0001
9 Bile Acid [EPC] 2 0.0001
See all drug classes enriched for association with GRANULICATELLA BACTERAEMIA